Lupin appoints Spiro Gavaris as President of U.S. Generics Business
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
This product is based on Osmotic Controlled Release Oral Delivery System technology
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
The company sees the business reaching $100mn
Subscribe To Our Newsletter & Stay Updated